Doctor examines the link between Guillain-Barr- syndrome and H1N1 vaccination

Personal view: Should I have an H1N1 flu vaccination after Guillain-Barr- syndrome?

A doctor who developed Guillain-Barr- syndrome will consider having the swine flu jab when she returns to work this autumn, despite claims that the vaccine is linked to an increased risk of the disease.

Laura Claire Price, a specialist in respiratory and intensive care medicine, examines the reasons why the vaccine might cause the syndrome, reviews the current evidence, and concludes that she will consider having the jab when it becomes available.

"In view of the potential risks of flu infection as a healthcare professional, the lack of relapse of the syndrome in a sizeable number of people who have had the flu vaccine, and the lack of a persistent causal association, my current view is to consider having the jab when it becomes available," she writes.

Comments

  1. Marie  Marie United States says:

    "Will consider having the swine flu jab when she returns to work this autumn, DESPITE claims that the vaccine is linked to an increased risk of the disease."

    Yikes. Who wants to be treated by a doctor who plays russian roulette with her own health. Read what another doctor has to say about the vaccine and why she would NEVER have a flu shot:

    drtenpenny.com/swine_flu_hype.aspx

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives